1,225 research outputs found
Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?
Endometrial cancer is the most common gynaecological cancer in western countries. Radiotherapy remains the mainstay of postoperative management, but accumulating data show that adjuvant chemotherapy may display promising results after staging surgery. The prognosis of patients with metastatic disease remains disappointing with only one-year survival. Progestins represent an effective option, especially for those patients with low-grade estrogen and/or progesterone receptor positive disease. Chemotherapy using the combination of paclitaxel, doxorubicin, and cisplatin is beneficial for patients with advanced or metastatic disease after staging surgery and potentially for patients with early-stage disease and high-risk factors. Toxicity is a point in question; however, the combination of paclitaxel with carboplatin may diminish these concerns. In women with multiple medical comorbidities, single-agent chemotherapy may be better tolerated with acceptable results. Our increased knowledge of the molecular aspects of endometrial cancer biology has paved the way for clinical research to develop novel targeted antineoplastic agents (everolimus, temsirolimus, gefitinib, erlotinib, cetuximab, trastuzumab, bevacizumab, sorafenib) as more effective and less toxic options. Continued investigation into the molecular pathways of endometrial cancer development and progression will increase our knowledge of this disease leading to the discovery of novel, superior agents
Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes
This review attempts to outline the alternative measures and interventions used in bloodless surgery in the field of gynecologic oncology and demonstrate their effectiveness. Nowadays, as increasingly more patients are expressing their fears concerning the potential risks accompanying allogenic transfusion of blood products, putting the theory of bloodless surgery into practice seems to gaining greater acceptance. An increasing number of institutions appear to be successfully adopting approaches that minimize blood usage for all patients treated for gynecologic malignancies. Preoperative, intraoperative and postoperative measures are required, such as optimization of red blood cell mass, adequate preoperative plan and invasive hemostatic procedures, assisting anesthetic techniques, individualization of anemia tolerance, autologous blood donation, normovolemic hemodilution, intraoperative cell salvage and pharmacologic agents for controlling blood loss. An individualised management plan of experienced personnel adopting a multidisciplinary team approach should be available to establish non-blood management strategies, and not only on demand of the patient, in the field of gynecologic oncology with the use of drugs, devices and surgical-medical techniques
On the semi-annual variation of relativistic electrons in the outer radiation belt
The nature of the semi-annual variation in the relativistic electron fluxes in the Earth's outer radiation belt is investigated using Van Allen Probes (MagEIS and REPT) and Geostationary Operational Environmental Satellite Energetic Particle Sensor (GOES/EPS) data during solar cycle 24. We perform wavelet and cross-wavelet analysis in a broad energy and spatial range of electron fluxes and examine their phase relationship with the axial, equinoctial and Russell–McPherron mechanisms. It is found that the semi-annual variation in the relativistic electron fluxes exhibits pronounced power in the 0.3–4.2 MeV energy range at L shells higher than 3.5, and, moreover, it exhibits an in-phase relationship with the Russell–McPherron effect, indicating the former is primarily driven by the latter. Furthermore, the analysis of the past three solar cycles with GOES/EPS indicates that the semi-annual variation at geosynchronous orbit is evident during the descending phases and coincides with periods of a higher (lower) high-speed stream (HSS) (interplanetary coronal mass ejection, ICME) occurrence
Flow Cytometry as a Diagnostic Tool in the Early Diagnosis of Aggressive Lymphomas Mimicking Life-Threatening Infection
Aggressive lymphomas can present with symptoms mimicking life-threatening infection. Flow cytometry (FC) is usually recommended for the classification and staging of lymphomas in patients with organomegaly and atypical cells in effusions and blood, after the exclusion of other possible diagnoses. FC may also have a place in the initial diagnostic investigation of aggressive lymphoma. Three cases are presented here of highly aggressive lymphomas in young adults, which presented with the clinical picture of fever of unknown origin (FUO) in patients severely ill. All followed a life-threatening clinical course, and two developed the hemophagocytic syndrome (HPS), but microbiological, immunological, and morphological evaluation and immunohistochemistry (IHC) failed to substantiate an early diagnosis. FC was the technique that provided conclusive diagnostic evidence of lymphoma, subsequently verified by IHC. Our experience with these three cases highlights the potential role of FC as an adjunct methodology in the initial assessment of possible highly aggressive lymphoma presenting with the signs and symptoms of life-threatening infection, although the definitive diagnosis should be established by biopsy. In such cases, FC can contribute to the diagnosis of lymphoma, independently of the presence of HPS
Economic evaluation of road user related measures. Deliverable 4.3 of the H2020 project SafetyCube
Safety CaUsation, Benefits and Efficiency (SafetyCube) is a European Commission supported
Horizon 2020 project with the objective of developing an innovative road safety Decision Support
System (DSS). The DSS will enable policy-makers and stakeholders to select and implement the
most appropriate strategies, measures, and cost-effective approaches to reduce casualties of all
road user types and all severities.
This document is the third deliverable (4.3) of work package 4, which is dedicated to the economic
evaluation - mainly by means of a cost-benefit analysis - of road user related safety measures [...continues]
CENTRAL OBESITY SEEMS TO HAVE THE HIGHEST PREDICTIVE VALUE AMONG ALL OTHERS ANTHROPOMETRIC INDICES FOR THE FIVE-YEAR INCIDENCE OF HYPERTENSION IN APPARENTLY HEALTHY INDIVIDUALS: THE ATTICA STUDY
The Adoption of Mediterranean Diet Attenuates the Development of Acute Coronary Syndromes in People with the Metabolic Syndrome
OBJECTIVES: In this work we investigated the effect of the consumption of the Mediterranean diet on coronary risk, in subjects with the metabolic syndrome. METHODS: During 2000–2002, we randomly selected, from all Greek regions, 848 hospitalised patients (695 males, 58 ± 10 & 153 females, 65 ± 9 years old) with a first event of acute coronary syndrome and 1078 frequency matched, by sex, age, region controls, without any suspicious for cardiovascular disease. Nutritional habits were evaluated through a validated questionnaire, while the metabolic syndrome was defined according to the NCEP ATP III criteria. Mediterranean diet was defined according to the guidelines of the Division of Nutrition/Epidemiology, of Athens Medical School. RESULTS: Of the 1926 participants, 307 (36.2%) of the patients and 198 (18.4%) of the controls (P < 0.001) met the ATP III criteria. This was related with 2fold adjusted coronary risk (odds ratio = 2.35, 95% 1.87 – 2.84) in subjects with the metabolic syndrome as compared with the rest of them. No differences were observed concerning the prevalence of the metabolic syndrome and sex of subjects, after adjustment for group of study (P > 0.1). Eighty (26%) of the patients and 70 (35%) of the controls (P < 0.01) with the metabolic syndrome were "closer" to the Mediterranean diet. Multivariate analysis revealed that the adoption of this diet is associated with a 35% (odds ratio = 0.65, 95% 0.44 – 0.95) reduction of the coronary risk in subjects with the metabolic syndrome, after adjusting for age, sex, educational and financial level and the conventional cardiovascular risk factors. CONCLUSION: Consequently, the adoption of Mediterranean diet seems to attenuate the coronary risk in subjects with the metabolic syndrome
- …